Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1973 Aug;1:262–265.

Immunotherapy for acute myelogenous leukaemia.

R Powles
PMCID: PMC2149078  PMID: 4531352

Full text

PDF
262

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crowther D., Powles R. L., Bateman C. J., Beard M. E., Gauci C. L., Wrigley P. F., Malpas J. S., Fairley G. H., Scott R. B. Management of adult acute myelogenous leukaemia. Br Med J. 1973 Jan 20;1(5846):131–137. doi: 10.1136/bmj.1.5846.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Currie G. A. Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer. Br J Cancer. 1972 Jun;26(3):141–153. doi: 10.1038/bjc.1972.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Mathé G. Approaches to the immunological treatment of cancer in man. Br Med J. 1969 Oct 4;4(5674):7–10. doi: 10.1136/bmj.4.5674.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Powles R. L., Balchin L. A., Fairley G. H., Alexander P. Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J. 1971 Feb 27;1(5747):486–489. doi: 10.1136/bmj.1.5747.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Whitecar J. P., Jr, Bodey G. P., Freireich E. J., McCredie K. B., Hart J. S. Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults. Cancer Chemother Rep. 1972 Aug;56(4):543–550. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES